C. Shortt

THE IMPORTANCE OF INTRODUCING COLONOSCOPY SCREENING IN THE ADULT CYSTIC FIBROSIS PATIENTS: A SINGLE TERTIARY REFERRAL CENTRE ANALYSIS

Jayne Doherty, Melissa M. McCarthy, C. Fleming, C. Shortt et autres

Aims The risk of colorectal cancer (CRC) in patients with cystic fibrosis (PWCF) is 10times greater than the general population and 30times greater post-transplant. Due to this new screening guidelines were published in Gastroenterology by the CF Colorectal Cancer Screening Task Force …

ie (code pays fourni par la source)

IMPROVING PATIENT EDUCATION AND THE TRANSITION PROCESS USING VIRTUAL REALITY

Tamara Vagg, C. Shortt, C. Fleming, Barry J. Plant et autres

For those diagnosed with a chronic condition at an early age, such as Cystic Fibrosis, transition from a paediatric care facility to an adult orientated facility is often inevitable. Patients can feel anxious and nervous as they are unfamiliar with their new …

Designing Heterogeneous-mHealth Apps for Cystic Fibrosis Adults

Tamara Vagg, C. Shortt, C. Fleming, M. J. H. McCarthy et autres

In this chapter, we will discuss the design and development of a patient passport mHealth application for Cystic Fibrosis adults from ideation to app-store release. By allowing the patients access to their own unique data, it is anticipated that it will be …

ie (code pays fourni par la source)

P026 Real-world Orkambi Cohort Cork study (ROCKS) - a prospective three months’ analysis addressing the impact of CFTR modulation in patients with cystic fibrosis homozygous for ΔF508del CFTR

Parniya Arooj, Nicola J. Ronan, Yvonne McCarthy, Mary Beryl Daly et autres

MHealth and Serious Game Analytics for Cystic Fibrosis Adults

Tamara Vagg, You Yuan Tan, C. Shortt, Claire Hickey et autres

Cystic Fibrosis is the most common life limiting genetic disease affecting Caucasians. With life expectancy for these patients rising, there is need to investigate interventions for a CF adult that does not impede on their busy lifestyle. This research describes an mHealth …

ie (code pays fourni par la source)

A mHealth Patient Passport for Adult Cystic Fibrosis Patients

Tamara Vagg, C. Shortt, Claire Hickey, Joseph A. Eustace et autres

ie (code pays fourni par la source)

CORK Study in Cystic Fibrosis

Nicola J. Ronan, Gisli G. Einarsson, ‎Maria Twomey, Denver Mooney et autres

ie, gb (code pays fourni par la source)

A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis

Fiona Fouhy, Nicola J. Ronan, Órla O’Sullivan, Yvonne McCarthy et autres

Cystic Fibrosis (CF) and its treatment result in an altered gut microbiota composition compared to non-CF controls. However, the impact of this on gut microbiota functionality has not been extensively characterised. Our aim was to conduct a proof-of-principle study to investigate if …

ie (code pays fourni par la source)

232 Lumacaftor/Ivacaftor is associated with a significant improvement in walk test and reduction in sweat chloride in a cohort of homozygous F508del CF patients with severe disease – a single centre experience

Nicola J. Ronan, Yvonne McCarthy, Komlanvi James, Parniya Arooj et autres

157 Ivacaftor does not produce a significant change in anti-Pseudomonas aeruginosa antibodies

A. G. Collins, Nicola J. Ronan, Yvonne McCarthy, Mary M. Daly et autres

Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection

Daniel G. Burke, Michael J. Harrison, C. Fleming, Melissa M. McCarthy et autres

ie (code pays fourni par la source)

217 Medical outcomes post transition of clinical care from a paediatric cystic fibrosis care model to an adult cystic fibrosis care model – an Irish perspective

Kenneth P Thornton, Nicola J. Ronan, C. Shortt, Michael McCarthy et autres